Dr. Stacey W. Steeves, MD
Neurology (Neurology Physician)
370 E 9th Ave Ste 106
Salt Lake City, UT 84103
Who else practices at this address →
Salt Lake County includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 125
Licensed in Washington since 2010, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
UT license 14191822-1205 · WA license MD60140035 (first issued 2010; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Dr John Foley LLC (10 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 125
- Services billed
- 39,577
- Patients’ average age
- 67
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 34,600 | 53 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 171 | 53 |
| Established patient office or other outpatient visit, 30-39 minutes | 154 | 91 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Aimovig Autoinjector (erenumab-aooe) Other prescribers in Salt Lake City, UT | 189 |
| Topiramate Other prescribers in Salt Lake City, UT | 120 |
| Sumatriptan Succinate Other prescribers in Salt Lake City, UT | 96 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Salt Lake City, UT | 93 |
| Ondansetron Odt (ondansetron) Other prescribers in Salt Lake City, UT | 84 |
| Gabapentin Other prescribers in Salt Lake City, UT | 80 |
| Quetiapine Fumarate Other prescribers in Salt Lake City, UT | 73 |
| Duloxetine Hcl Other prescribers in Salt Lake City, UT | 71 |
| Qulipta (atogepant) Other prescribers in Salt Lake City, UT | 68 |
| Pregabalin Other prescribers in Salt Lake City, UT | 52 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 58 payments worth $17,337 in total to this clinician.
| AbbVie Inc. | $16,210 |
|---|---|
| Tg Therapeutics, Inc. | $302 |
| Amgen Inc. | $77.06 |
| Biogen, Inc. | $76.95 |
| Genzyme Corporation | $75.00 |
| Csl Behring | $63.80 |
| Genentech, Inc. | $51.85 |
| Teva Pharmaceuticals USA, Inc. | $48.59 |
| Compensation for services other than consulting (speaking, faculty) | $15,881 |
|---|---|
| Food and Beverage | $1,456 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,675 |
| AbbVie Inc. Sep 30, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,675 |
| AbbVie Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,675 |
| AbbVie Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,675 |
| AbbVie Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $1,181 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.